Skip to main content

Table 1 Baseline characteristics of members of the Epidemiology of Diabetes Complications (EDC) Study DNA methylation sub-cohort who were free of any CVD at baseline

From: DNA methylation and 28-year cardiovascular disease risk in type 1 diabetes: the Epidemiology of Diabetes Complications (EDC) cohort study

Characteristic

Overall (n = 368)

Incident CVD (n = 172)

No CVD (n = 196)

p value‡

Age, years

29.2 (7.7)

32.2 (7.4)

26.5 (7.0)

< 0.001

Type 1 diabetes duration, years

20.9 (7.6)

24.0 (7.8)

18.1 (6.3)

< 0.001

Age at type 1 diabetes Onset, years

8.3 (4.1)

8.2 (3.8)

8.3 (4.3)

0.927

Female sex, % (n)

46.3% (176)

50.0% (86)

45.9% (90)

0.581

≥ Bachelor’s degree, % (n)

35.3% (130)

29.7% (51)

40.3% (79)

0.003

HbA1c, %

9.0 (1.5)

9.3 (1.5)

8.9 (1.5)

0.007

HbA1c, mmol/mol

75.3 (16.4)

77.7 (16.6)

73.2 (16.0)

Smoking status, % (n)

 Never

63.9% (235)

58.1% (100)

68.9% (135)

0.001

 Past

15.5% (57)

15.7% (27)

15.3% (30)

 Current

20.7% (76)

26.2% (45)

15.8% (31)

Smoking, pack-years*

0 (0, 3)

0 (0, 10)

0 (0, 0.2)

< 0.001

Body Mass Index, kg/m2

24.2 (3.3)

24.8 (3.3)

23.7 (3.2)

< 0.001

Insulin dose, insulin units/kg body weight

0.78 (0.25)

0.77 (0.25)

0.79 (0.24)

0.122

MDI† or insulin pump use, % (n)

13.8% (50)

13.0% (22)

14.5% (28)

0.437

Self-monitoring of blood glucose, % (n)

72.6% (267)

72.0% (124)

73.0% (143)

0.925

Estimated glucose disposal rate, mg/kg/min

7.55 (2.01)

6.95 (2.14)

8.08 (1.74)

< 0.001

Total cholesterol (mg/dl)

186.8 (40.5)

202.4 (38.6)

173.1 (37.1)

< .0001

HDLc (mg/dl)

53.4 (12.4)

53.5 (12.7)

53.4 (12.3)

0.774

Non-HDLc (mg/dl)

133.4 (39.1)

148.9 (38.3)

119.7 (34.8)

< 0.001

Triglycerides (mg/dl)*

80.0 (57.0, 118.0)

95.5 (67.8, 137.3)

67.0 (53.0, 118.0)

< 0.001

Lipid medication, % (n)

1.1% (4)

2.3% (4)

0% (0)

0.008

Systolic blood pressure (mmHg)

113.8 (15.8)

118.1 (17.6)

110.0 (12.9)

< 0.001

Diastolic blood pressure (mmHg)

72.5 (11.0)

74.5 (12.1)

70.7 (9.5)

< 0.001

Hypertension, % (n)

17.4% (64)

26.7% (46)

9.2% (18)

< 0.001

Blood pressure medication, % (n)

11.0% (40)

18.0% (31)

4.6% (9)

< 0.001

Pulse rate, bpm

75.7 (10.8)

77.4 (10.5)

74.2 (10.8)

0.005

Albumin excretion rate, µg/min*

11.4 (5.5, 22.9)

19.6 (8.1, 288.5)

8.9 (5.5, 73.9)

< 0.001

Estimated glomerular filtration rate, ml/min/1.73 m2

112.7 (31.1)

106.7 (32.4)

117.9 (28.9)

< 0.001

White blood cell count, × 109 cells/l

6.9 (2.1)

7.3 (2.0)

6.7 (7.3)

< 0.001

  1. Values are mean (SD) unless specified. *median (p25, p75), †Multiple Daily Injections (≥ 3 insulin injections per day), ‡p value for the unadjusted association between each risk factor and CVD incidence from Cox regression